Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by fredgoodwinson on Jan 29, 2021 11:31am

GBM

https://theralase.com/theralase-lead-anti-cancer-drug-effective-in-the-destruction-of-brain-cancer-when-activated-by-x-rays/

 

Just a reminder that well over 3 years`ago Theralase highlighted the realistic possibility of the non-invasive destruction of brain tumour.

 

Might they now tell us that this is indeed the chosen route and provide us with a timetable to human trials?

Comment by Hankerchief on Jan 29, 2021 12:01pm
Fred,  This is amazing stuff IMO.  Just can't believe they have not been able to advance this treatment for three years.  Could have helped a lot of folks.
Comment by CancerSlayer on Jan 29, 2021 3:33pm
  Agree, it's been a long time Hank...Bypassing high-risk surgery would certainly be the way to go for GBM.  However, activation by basic x-ray or other form of external radiation is constantly evolving, which could partially explain the 3 year delay imo.  Though x-ray led to an excellent 75% tumor destruction preclinically, using more targeted or high-resolution/3-D imaging ...more  
Comment by fredgoodwinson on Jan 29, 2021 4:11pm
Theralase aren’t the only biotechs and - thank goodness - new treatments are already improving prospects for those with GBM and other until recently difficult-to-treat cancers. Hopefully Roswell Park and TLD-1433/Digilum will shortly be added to the list.   If they could do it with Rutherrin and x-ray though it would be so greatly less involved and  more humane - like something out ...more  
Comment by menoalittle on Jan 29, 2021 4:28pm
>> like something out of Science Fiction. Elysium, no doubt. (skip the adds, but note the 1:00 mark in this trailer) https://youtu.be/hvGE2nP4ga8?t=53
Comment by fredgoodwinson on Jan 29, 2021 4:47pm
Yup - that`s the idea!
Comment by Pandora on Jan 29, 2021 4:49pm
Didn't see anything relevant but maybe it's part of the audio. Can you give a hint as to what one is looking for? or listening for?
Comment by menoalittle on Jan 29, 2021 5:18pm
oh yeah, it's definitely part of the audio.  (evidently gets missed completely without it) the girl in red, lying on the table? gets a body scan... (elaborated on in the actual movie. this is only a brief snapshot of it.) the audio after... "cancer cells removed" the visual on the screen then reads "100% clear"
Comment by TriumphSpitSix on Jan 29, 2021 6:23pm
Elysium debuted in 2013. Less than 10 years later and we're turning science-fiction into science-fact.
Comment by menoalittle on Mar 26, 2021 1:12pm
okay, dug around and found it again. always worth a reminder of how just close to reality science fiction often times turns out to be... __________________ (skip the adds, but note the 1:00 mark in this trailer) https://youtu.be/hvGE2nP4ga8?t=53 and it's definitely part of the audio.  (evidently gets missed completely without it) the girl in red, lying on the table? gets a body scan.. ...more  
Comment by Eoganacht on Jan 29, 2021 12:16pm
Hi Fred - as of Dec. 15 Shawn Shirazi was suggesting Fall of 2021 for GBM and NSCLC phase 1 trials. He didn't mention any details about the procedures though.
Comment by fredgoodwinson on Jan 29, 2021 1:29pm
Thanks Hank & Eog.My post didn`t read well as am actually not impatient  but can only imagine the impact when a wider public fully appreciates that for diseases currently with the bleakest prognoses and necessarily radical surgical procedures such as GBM (and possibly NSCLC???) it may prove possible to treat non-invasively via an intravenous injection and low dose exogenous x-ray. The ...more  
Comment by menoalittle on Jan 29, 2021 2:27pm
Anything further said about using TLD-1633(+ transferrin) for it, or is there still too long a runway for this "newer and improved version of TLD-1433" to be ready for GBM trials?
Comment by jicoop on Jan 29, 2021 2:36pm
I've been asking about this for some time as well. Remeber this news release, over 3 years ago, so what happened since ?  Excerpt below. Also, I am encorgaed by the US sites coming on board, the Phildelphia sites are very promising, as they encompass multiple loactions in the greater Phili area, where by contract , the Myrtle Beach clinic seems like a small mom and pop shop , excuse the ...more  
Comment by fredgoodwinson on Jan 29, 2021 3:23pm
Yes that`s a real puzzle re.TLD-1633.
Comment by tamarindo1 on Jan 29, 2021 5:53pm
Taken from an old discussion on transition metal complexes & PDT. Considering the potency of TLD1633, it may seem odd that TLD1433 was selected instead. TLD1433 was prioritized over the other compound for a number of reasons, including: (1) there were more synthetic steps required for producing TLD1633, and those steps were low yielding (unoptimized at that time) and required expensive ...more  
Comment by fredgoodwinson on Jan 30, 2021 7:10am
Thanks tamarindo - a direct explanation.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250